Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Drug Dev Ind Pharm ; 36(12): 1486-96, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20545515

ABSTRACT

OBJECTIVE: The objective of this study was to investigate the effects of sodium lauryl sulfate (SLS) from different sources on solubilization/wetting, granulation process, and tablet dissolution of BILR 355 and the potential causes. METHODS: The particle size distribution, morphology, and thermal behaviors of two pharmaceutical grades of SLS from Spectrum and Cognis were characterized. The surface tension and drug solubility in SLS solutions were measured. The BILR 355 tablets were prepared by a wet granulation process and the dissolution was evaluated. RESULTS: The critical micelle concentration was lower for Spectrum SLS, which resulted in a higher BILR 355 solubility. During wet granulation, less water was required to reach the same end point using Spectrum than Cognis SLS. In general, BILR 355 tablets prepared with Spectrum SLS showed a higher dissolution than the tablets containing Cognis SLS. Micronization of SLS achieved the same improved tablet dissolution as micronized active pharmaceutical ingredient. CONCLUSIONS: The observed differences in wetting and solubilization were likely due to the different impurity levels in SLS from two sources. This study demonstrated that SLS from different sources could have significant impact on wet granulation process and dissolution. Therefore, it is critical to evaluate SLS properties from different suppliers, and then identify optimal formulation and process parameters to ensure robustness of drug product manufacture process and performance.


Subject(s)
Azepines/chemistry , Pyridines/chemistry , Reverse Transcriptase Inhibitors/chemistry , Sodium Dodecyl Sulfate/chemistry , Surface-Active Agents/chemistry , Chemistry, Pharmaceutical , Micelles , Particle Size , Sodium Dodecyl Sulfate/standards , Solubility , Surface Tension , Surface-Active Agents/standards , Tablets
2.
J Am Chem Soc ; 128(25): 8199-210, 2006 Jun 28.
Article in English | MEDLINE | ID: mdl-16787084

ABSTRACT

A cancer candidate, compound 1, is a weak base with two heterocyclic basic nitrogens and five hydrogen-bonding functional groups, and is sparingly soluble in water rendering it unsuitable for pharmaceutical development. The crystalline acid-base pairs of 1, collectively termed solid acid-base complexes, provide significant increases in the solubility and bioavailability compared to the free base, 1. Three dicarboxylic acid-base complexes, sesquisuccinate 2, dimalonate 3, and dimaleate 4, show the most favorable physicochemical profiles and are studied in greater detail. The structural analyses of the three complexes using crystal structure and solid-state NMR reveal that the proton-transfer behavior in these organic acid-base complexes vary successively correlating with Delta pKa. As a result, 2 is a neutral complex, 3 is a mixed ionic and zwitterionic complex and 4 is an ionic salt. The addition of the acidic components leads to maximized hydrogen bond interactions forming extended three-dimensional networks. Although structurally similar, the packing arrangements of the three complexes are considerably different due to the presence of multiple functional groups and the flexible backbone of 1. The findings in this study provide insight into the structural characteristics of complexes involving heterocyclic bases and carboxylic acids, and demonstrate that X-ray crystallography and 15N solid-state NMR are truly complementary in elucidating hydrogen bonding interactions and the degree of proton transfer of these complexes.


Subject(s)
Amines/chemistry , Dicarboxylic Acids/chemistry , Heterocyclic Compounds/chemistry , Crystallography, X-Ray , Drug Design , Hydrogen Bonding , Hydrogen-Ion Concentration , Macromolecular Substances/chemistry , Magnetic Resonance Spectroscopy , Molecular Structure , Nitrogen Isotopes , Receptor, ErbB-2/antagonists & inhibitors , Solubility
SELECTION OF CITATIONS
SEARCH DETAIL
...